Liver transplantation is indicated for patients developing histologiocal evidence of cirrhosis. There is resolution of metabolic derangements after liver transplantation in patients with glycogen storage<unk>  type 3 (GSD 3). As hepatic abnormalities in GSD 3 are due to single-gene and cell-autonomous defect, the recurrence of primary liver<unk>  in the transplanted allograft in not possible. However, skeletal manifestations or cardiac manifestations does not correct even after liver transplantation.
Glycogen storage disease type III surgery
Glycogen storage disease type I surgery
Glucose-6-phosphate dehydrogenase deficiency surgery
Hemochromatosis surgery
Glycogen storage disease type III medical therapy
Zollinger-Ellison syndrome surgery
Glycogen storage disease type II medical therapy
Glycogen storage disease type I medical therapy